skip to navigationskip to main content

DTE Corporate Finance advises Quat-Chem on its sale to Neogen.

06 December 2016

DTE Corporate Finance is delighted to announce that they advised the Shareholders of Quat-Chem Limited (“Quat-Chem) on its sale to Nasdaq listed Neogen Corporation (“Neogen”).

Quat-Chem is a Rochdale-based chemical company specialising in the development and manufacture of biocidal hygiene products to control pathogenic, food spoilage micro-organisms in the Poultry & Livestock agriculture, Dairy farming, Food processing, and Healthcare sectors. The Company has shown consistent high growth for a number of years and aside from being active in the United Kingdom and European Union, Quat-Chem has a substantial international presence in the Middle East, North Africa, South East Asia, and the Far East.

Neogen develops and markets products dedicated to food and animal safety and aims to become the global biosecurity product leader. Their Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products. The acquisition will provide them with access to Quat-Chem’s broad line of products, chemical manufacturing facilities, personnel and existing business.

Dr. Rubinah Chowdhary, Quat-Chem’s scientific director said “Quat-Chem’s product development activities and its manufacturing capabilities in Europe provide a complementary fit to Neogen’s strategy of expanding its biosecurity business. The importance of biosecurity is internationally recognized as critical to safe-guarding livestock health and food safety. The demand for safe, performance tested disinfection products offers considerable potential; with Neogen’s expertise in biosecurity and its global reach, we feel Quat-Chem and its products are in good hands.”

Andy Humphrey and Stephen Moorcroft provided corporate finance advice to the shareholders. Andy said “Many months of hard work, by all parties, has led to a successful transaction. In particular, the long term strategy of the shareholders has delivered a perfect platform to allow Neogen to continue to increase their global footprint”.

View other news